Health technology assessment for eHealth and integrated care projects: Hands-on experience from the use of MAST framework
Friday, October 20, 2017, 9.30-14.15
Room PURIFIER 1
Objectives
To make decision-makers, researchers, healthcare professionals and other stakeholders familiar with the most widely used HTA framework for Technology Enabled Care, including telemedicine and integrated care services. MAST has been used from 2010 until now in more than 22 European countries (involving several tenths of different types of public and private organisations across Europe), 8 EU-funded projects with more than 20.000 care recipients and more than 10 other projects. Although different methods have been applied, including randomized controlled trials, observational studies and feasibility studies, all seven MAST domains have been assessed in all these projects. These projects vary in funding from EU from roughly 1 to 8 million Euros and in duration from 18 to 42 months.
Overall, the aim of MAST is to improve the possibilities for decision makers to choose the most appropriate ICT-enabled care services to be used in the most cost-effective way by providing a multidisciplinary assessment based on scientific methods and results.
FRIDAY 20/10/2017 || ROOM PURIFIER 1
| Chairs: Panos Stafylas, Marco d’Angelantonio, Members of the Board of Directors of MAST EEIG | |
|---|---|
| 10.00 – 10.15 | Welcome & introduction, Panos Stafylas, Marco d’Angelantonio |
| 10.15 – 10.30 | Objective and validity of MAST, Kristian Kidholm |
| 10.30 – 10.45 | Health & social situation and unmet needs, Marco d’Angelantonio |
| 10.45 – 11.00 | Assessment of technical characteristics, Panagiotis Bamidis |
| 11.00 – 11.15 | Ethical, legal and social aspects, Elena Stafyla |
| 11.15 – 11.30 | Discussion |
| 11.30 – 12.00 | COFFEE BREAK |
| 12.00 – 12.15 | Safety and clinical outcomes, George Dafoulas |
| 12.15 – 12.30 | Patients’ perspectives, Ane Fullaondo Zabala |
| 12.30 – 12.45 | Economic outcomes, sustainability and scalability of eHealth services, Panos Stafylas |
| 12.45 – 13.00 | The eHealth landscape in Greece. Opportunities for HTA, Haralampos Karanikas |
| 13.00 – 13.30 | Discussion |
| 13.30 – 14.00 | Invited Lecture. New assessment pathways for medicines and devices, Dimitrios Kouvelas |
| 14.00 – 14.15 | Conclusions, closing remarks, Panos Stafylas, Marco d’Angelantonio |